1.
Rheumatol Int
; 32(12): 4061-3, 2012 Dec.
Article
in English
| MEDLINE
| ID: mdl-21922339
ABSTRACT
A patient with chronic inflammatory demyelinating polyradiculoneuropathy and systemic lupus erythematosus arising after rubella vaccination was initially treated with plasmapheresis, corticosteroids and intravenous immunoglobulins, with partial response. After shift to rituximab, most clinical symptoms improved markedly, emphasizing the possible role of this monoclonal antibody in conventional therapy-resistant cases.